<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04922359</url>
  </required_header>
  <id_info>
    <org_study_id>2021PHB059-001</org_study_id>
    <nct_id>NCT04922359</nct_id>
  </id_info>
  <brief_title>Effect of Perioperative Lidocaine on Gastrointestinal Function Recovery After Lumbar Spine Surgery in Adults</brief_title>
  <official_title>Effect of Perioperative Lidocaine on Gastrointestinal Function Recovery After Lumbar Spine Surgery in Adults: a Multicenter, Randomized, Double-blind, Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wangjing Hospital, China Academy of Chinese Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital of Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal surgery often involves multiple segments. The trauma of surgery is large, the duration&#xD;
      of postoperative pain is long, and the pain is severe. Therefore, the use of opioids in&#xD;
      perioperative period is large. Although the application of * large amounts of opioids can&#xD;
      effectively inhibit pain, it will delay the recovery of urine retention, sedation,&#xD;
      respiratory depression and gastrointestinal function. The delayed recovery of&#xD;
      gastrointestinal function will increase the postoperative complications, and then increase&#xD;
      the length of hospital stay and the cost of patients. Therefore, reducing the dosage of&#xD;
      opioids to promote the recovery of gastrointestinal function has become the research&#xD;
      direction. Intravenous lidocaine has been proved to be effective in reducing the dosage of&#xD;
      opioids during the perioperative period of gastrointestinal surgery and promoting the&#xD;
      recovery of postoperative gastrointestinal function. However, there are few studies on the&#xD;
      application of lidocaine during the perioperative period of spinal surgery, especially the&#xD;
      impact on postoperative gastrointestinal function. In this study, a multicenter, randomized,&#xD;
      double-blind, controlled study was conducted to explore the effect of perioperative lidocaine&#xD;
      on the recovery of gastrointestinal function after adult lumbar surgery. We hypothesized that&#xD;
      lidocaine could shorten the recovery time of gastrointestinal function after lumbar surgery&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2021</start_date>
  <completion_date type="Anticipated">May 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First anal exhaust time</measure>
    <time_frame>Day 0</time_frame>
    <description>Time of first anal exhaust after operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First defecation time</measure>
    <time_frame>Day 0</time_frame>
    <description>Time of first defecation after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First diet time</measure>
    <time_frame>Day 0</time_frame>
    <description>Time of first feeding after operation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to get out of bed</measure>
    <time_frame>Day 0</time_frame>
    <description>Time to get out of bed after operation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Spinal Surgery</condition>
  <condition>Lidocaine</condition>
  <condition>Pain</condition>
  <condition>Opioid Consumption</condition>
  <condition>Gastrointestinal Dysfunction</condition>
  <arm_group>
    <arm_group_label>Experimental: Lidocaine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Comparator: comparator group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocain</intervention_name>
    <description>Patients received 1.5mg/kg of intravenous lidocaine during induction of anesthesia and 1.5 mg/kg/h for anesthesia maintenance.</description>
    <arm_group_label>Experimental: Lidocaine group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>Patients received 0.075ml/kg of intravenous normal saline during induction of anesthesia and 0.075ml/kg/h for anesthesia maintenance.</description>
    <arm_group_label>Placebo Comparator: comparator group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. age 60 to 80;&#xD;
&#xD;
          2. ASA physical status score of I, II or III;&#xD;
&#xD;
          3. Scheduled to undergo a posterior lumbar surgery;&#xD;
&#xD;
          4. Ideal body weightâ‰¤80 kg;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Those who are refused to be included;&#xD;
&#xD;
          2. Those who are allergic to the drugs used in this study;&#xD;
&#xD;
          3. Emergency operation&#xD;
&#xD;
          4. Degree II or III atrioventricular block&#xD;
&#xD;
          5. heart failure&#xD;
&#xD;
          6. History of ALS, preexcitation or active dysrhythmia&#xD;
&#xD;
          7. Severe liver injury (bilirubin &gt; 1.46 mg/dl)&#xD;
&#xD;
          8. Severe renal injury (creatinine clearance &lt; 30 ml/min) or Renal failure&#xD;
&#xD;
          9. History of epilepsy&#xD;
&#xD;
         10. History of porphyria&#xD;
&#xD;
         11. Preoperative hypotension (SBP&lt; 90mmHg)&#xD;
&#xD;
         12. Drug contraindications of NSAIDs&#xD;
&#xD;
         13. Allergic to anaesthetic&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jie Gu, attending</last_name>
    <phone>15210886376</phone>
    <email>hmugujie@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 6, 2021</study_first_submitted>
  <study_first_submitted_qc>June 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 6, 2021</last_update_submitted>
  <last_update_submitted_qc>June 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Yi Feng, MD</investigator_full_name>
    <investigator_title>Head of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Lidocaine</keyword>
  <keyword>Gastrointestinal Dysfunction</keyword>
  <keyword>Spinal surgery</keyword>
  <keyword>Opioid consumption</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

